Burjeel opens $1.5bn sukuk shelf for 18-asset UAE expansion

Burjeel Holdings listed a $1.5 billion sukuk programme in London on 22 June 2026, creating debt capacity for 18 planned healthcare assets through 2028.

For healthcare executives, the signal is immediate: Burjeel Holdings is preparing capital for a larger push into Dubai hospitals, day surgery, fertility and higher-acuity services before rivals lock up the same consultants, payer contracts and licensed sites.

Why the funding route matters

The programme was created through Burjeel Sukuk Limited and admitted to the London Stock Exchange International Securities Market, according to Gulf News. Sukuk give Burjeel Holdings access to international debt investors under an Islamic finance structure.

Burjeel Holdings said the framework will support investment in specialist medical care, research, medical education, digital transformation and AI-based healthcare. That points to capital needs beyond bed count: doctors, clinical platforms, data systems and services with stronger reimbursement potential.

“Receiving first-time ratings from two of the world’s leading credit rating agencies is an important milestone for Burjeel Holdings.” — Dr. Shamsheer Vayalil, Chairman and CEO, Burjeel Holdings

The financing follows a stronger earnings base. Burjeel Holdings reported AED 5.5 billion in 2025 revenue, up 9.5%, and net profit of AED 503 million, up 39.5%, in its 2025 results release. In Q1 2026, net profit rose 44.5% to AED 57 million, while EBITDA reached AED 201 million, according to Burjeel Holdings’ Q1 2026 statement.

Where the capital could go

Burjeel Holdings’ published strategy lists 18 planned healthcare assets between 2026 and 2028. The UAE pipeline includes two hospitals in Dubai, four day surgery centres, six medical centres and two Trust Fertility Clinic branches in Al Ain and Dubai, according to the company’s strategy page.

• Dubai Health Authority (DHA) exposure will rise if Burjeel Holdings executes the two hospital plan in Dubai.
• Department of Health Abu Dhabi (DOH) remains central because Burjeel Holdings has major assets in Abu Dhabi and Al Ain.
• Ministry of Health and Prevention (MOHAP) becomes relevant if the group expands day surgery or medical centres into the Northern Emirates.
• Saudi Arabia is the larger regional test, with capital needs tied to licensing, payer contracts and specialist hiring.

Competing hospital groups should read the shelf as a financing signal, not a completed build-out. Burjeel Holdings now has a structure that can support multi-year growth in higher-value services, which puts pressure on rivals to protect consultant rosters, referral flows and premium specialties before new capacity opens.

What executives should watch

The sukuk programme does not mean Burjeel Holdings has drawn the full $1.5 billion. It creates a shelf for future issuance. The next material disclosures are the size, tenor, coupon and use of proceeds for any drawdown.

CFOs should watch whether net debt stays inside management’s guidance of less than 2.5 times pre-IFRS 16 EBITDA, which Burjeel Holdings referenced in its Q1 2026 investor materials. A large draw for greenfield hospitals would carry a different risk profile than debt for outpatient centres or targeted acquisitions.

COOs should treat the financing as an early warning on workforce and licensing competition. New hospitals and day surgery centres need licensed nurses, surgeons, anaesthetists, imaging staff and revenue-cycle teams before opening day. In Dubai, that means DHA licensing and facility approvals. In Abu Dhabi and Al Ain, it means DOH approval pathways. In the Northern Emirates, MOHAP remains the operating gatekeeper.

The number to remember is $1.5 billion. If Burjeel Holdings converts the programme into lower-cost funding and opens assets on schedule through 2028, the first market effects are likely to show up in specialist hiring, insurer negotiations and outpatient referral flows.